Lloyd A. Rowland, General Counsel: CytomX Therapeutics CTMX Sell · Filed 24/03/21

Trade details

Type: Insider sale
Amount: $11,010.12
Shares · price: 5,268 sh · $2.09 a share
Held after: 117,728 sh
Stock: CytomX Therapeutics CTMX
Person: Lloyd A. RowlandGeneral Counsel
Trade date: 24/03/19
Filed: 24/03/21
Days to filing: 2 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/18~24/04/18

Lloyd A. Rowland's recent trades

Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$6,122
10,203 sh
$6,122
Filed 25/03/20
Traded 25/03/18
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$7,132
5,486 sh
$7,132
Filed 23/09/22
Traded 23/09/22
Lloyd A. RowlandGeneral Counsel
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,033
2,037 sh
$4,033
Filed 23/03/20
Traded 23/03/16